MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
BeiGene, Ltd. P/B Ratio 2011-2026 | BGNE
Annual P/B Ratio BeiGene, Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 75.9 | 61.4 | 66.4 | 47.7 | 89.7 | 9.42 | 4 | 8.24 | 3.84 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 89.7 | 3.84 | 40.7 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Amgen
AMGN
|
2.19 | $ 350.62 | 0.81 % | $ 189 B |  USA |
 |
Heron Therapeutics
HRTX
|
13.8 | $ 0.8 | 2.35 % | $ 133 M | USA |
 |
Altimmune
ALT
|
1.41 | $ 3.46 | 3.44 % | $ 305 M | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 219.42 | -1.11 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
Incyte Corporation
INCY
|
3.77 | $ 90.74 | -0.04 % | $ 17.7 B | USA |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Inovio Pharmaceuticals
INO
|
1.88 | $ 1.62 | 2.22 % | $ 35.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Cullinan Management
CGEM
|
2.2 | $ 12.92 | 1.41 % | $ 778 M | USA |
 |
Inventiva S.A.
IVA
|
6.02 | $ 6.13 | 6.06 % | $ 138 M | France |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
3.07 | $ 16.76 | -1.41 % | $ 832 M | Britain |
 |
Calithera Biosciences
CALA
|
19.6 | - | -10.95 % | $ 876 K | USA |
 |
Cara Therapeutics
CARA
|
0.949 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
0.00635 | - | - | $ 3.74 B | USA |
 |
Bellerophon Therapeutics
BLPH
|
31 | - | -74.18 % | $ 955 K | USA |
 |
Kamada Ltd.
KMDA
|
0.85 | $ 8.23 | -0.24 % | $ 260 M | Israel |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | USA |
 |
Karyopharm Therapeutics
KPTI
|
-0.000393 | $ 7.06 | -7.47 % | $ 860 K | USA |
 |
Clovis Oncology
CLVS
|
-0.829 | - | -7.23 % | $ 13 M | USA |
 |
Keros Therapeutics
KROS
|
1.69 | $ 11.27 | 2.83 % | $ 419 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Denali Therapeutics
DNLI
|
2.47 | $ 21.23 | 5.26 % | $ 3.49 B | USA |
 |
Longeveron
LGVN
|
2.97 K | $ 0.95 | -3.52 % | $ 16.7 B | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.3 | 1.3 % | $ 714 M | Canada |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |